ImClone Systems - Ownership and Business Overview

Life ScienceCompany

ImClone Systems Ownership

Who owns ImClone Systems?

ImClone Systems is owned by Eli Lilly. It was acquired on October 6, 2008.

ImClone Systems Business Overview

Where is ImClone Systems headquartered?

ImClone Systems is headquartered in Bridgewater, New Jersey.

How many employees does ImClone Systems have?

ImClone Systems has 1,128 employees.

What sector is ImClone Systems in?

ImClone Systems is a life science company.

When was ImClone Systems founded?

ImClone Systems was founded in 1984.

Life Science M&A Summary in 2008

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view all 129 acquisitions of life science companies in 2008, including 25 acquisitions by private equity firms, and 104 by strategics.

ImClone Systems, Inc.

440 Route 22 East,
Bridgewater, New Jersey 08807
United States,
(908) 541-8100
www.imclone.com

ImClone Systems is a fully integrated biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. The company's research and development programs include growth factor blockers and angiogenesis inhibitors. ImClone Systems' headquarters and research operations are located in New York City, with additional administration and manufacturing facilities in Branchburg, New Jersey.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.